Document is current
Any future updates will be listed below
-
Authors
Kang, Byungjun https://orcid.org/0000-0001-7220-801X
Jeong, Eunseon https://orcid.org/0000-0003-0513-8693
Han, Seung Yeop
Heo, Jeong Hyun https://orcid.org/0000-0002-9734-5376
Lee, Yunam https://orcid.org/0009-0003-6833-8032
Choi, Suah
Choi, Yunjung
Kang, Donyoung https://orcid.org/0000-0003-2680-7489
Hwang, Youn-Hoo
Lee, Jiin
Seo, Jung Hwa https://orcid.org/0000-0002-8489-7972
Kim, Jinyoung
Jeong, Inhea https://orcid.org/0000-0003-2226-4755
Kim, Enji https://orcid.org/0000-0002-4934-8951
Lee, Juyoung
Kim, Dae-Eun https://orcid.org/0000-0002-6095-5138
Park, Jang-Ung https://orcid.org/0000-0003-1522-4958
Cho, Sung-Rae https://orcid.org/0000-0003-1429-2684
Jin, Yoonhee
Cho, Seung-Woo https://orcid.org/0000-0001-8058-332X
Lee, Hyungsuk https://orcid.org/0000-0002-7873-7163
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (2021R1A2C2009070)
- License Information
-
More Information
Article History
Received: 25 October 2023
Accepted: 7 April 2025
First Online: 5 May 2025
Competing interests
: S.-W.C. is a chief technology officer (CTO) of Cellartgen, Inc., Republic of Korea. The remaining authors declare no competing interests.
